NCT07327710

Brief Summary

To evaluate the efficacy and safety of treating peripheral facial palsy using a non-invasive brain-computer interface combined with transcranial direct current stimulation (tDCS).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
33mo left

Started Nov 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Nov 2025Dec 2028

Study Start

First participant enrolled

November 30, 2025

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

December 25, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 8, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

January 8, 2026

Status Verified

December 1, 2025

Enrollment Period

2.1 years

First QC Date

December 25, 2025

Last Update Submit

December 25, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Improvement in House-Brackmann (HB) grading

    At 0,2,4,8 and 12 weeks.

  • Sunnybrook Facial Grading System score.

    At 0,2,4,8 and 12 weeks.

  • Static and dynamic facial symmetry scores.

    At 0,2,4,8 and 12 weeks.

  • Degree of facial muscle EMG activation and changes in EEG functional connectivity.

    At 0,2,4,8 and 12 weeks.

Secondary Outcomes (1)

  • Adverse events

    At 0,2,4,8 and 12 weeks.

Study Arms (3)

Group A: Standard Therapy

PLACEBO COMPARATOR

Standard therapy.

Other: Standard Therapy

Group B: Pulsed Radiofrequency + Standard Therapy

PLACEBO COMPARATOR

Standard Therapy and Pulsed Radiofrequency Therapy.

Procedure: Pulsed Radiofrequency (PRF)Other: Standard Therapy

Group C:BCI + tDCS + Pulsed Radiofrequency Treatment + Standard Therapy

EXPERIMENTAL

BCI + tDCS + Pulsed Radiofrequency Treatment + Standard Therapy.

Procedure: Brain-Computer Interface (BCI)Procedure: Pulsed Radiofrequency (PRF)Other: Standard Therapy

Interventions

1. BCI Therapy: Real-time feedback drives NMES (neuromuscular electrical stimulation) of the target facial muscles. Each session lasts 30 minutes, 3-5 times per week, for a total of 4 weeks. 2. tDCS Therapy: Applied to the regions corresponding to the branches of the facial nerve. A constant current (usually 0.5-2 mA) is delivered for 20-30 minutes per session, 5-20 sessions per course. Standard treatment frequency is once daily, 5-6 times per week, with a continuous course of 2-4 weeks. Each stimulation session typically lasts 20-30 minutes.

Also known as: transcranial Direct Current Stimulation (tDCS)
Group C:BCI + tDCS + Pulsed Radiofrequency Treatment + Standard Therapy

Acute-phase "shock" protocol: Within 7 days of onset, a single pulsed radiofrequency treatment is applied to the extracranial segment of the facial nerve. Depending on recovery, the treatment may be repeated 1-2 weeks later. Chronic-phase (sequelae) "shock" protocol: Administered once every 1-4 weeks, for a total of 1-4 sessions.

Group B: Pulsed Radiofrequency + Standard TherapyGroup C:BCI + tDCS + Pulsed Radiofrequency Treatment + Standard Therapy

Includes facial muscle function training, physiotherapy, hot and cold compresses, and neurotrophic drug treatment.

Group A: Standard TherapyGroup B: Pulsed Radiofrequency + Standard TherapyGroup C:BCI + tDCS + Pulsed Radiofrequency Treatment + Standard Therapy

Eligibility Criteria

Age18 Years - 75 Years
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18-70 years, regardless of sex.
  • Unilateral peripheral facial nerve palsy.
  • House-Brackmann (HB) grade II-VI.
  • Able to cooperate with target facial movement tasks and provide written informed consent, with intact cognitive function and good communication ability.
  • Good skin condition, with no severe skin lesions or facial skin grafts; no implanted electronic devices such as cardiac pacemakers or deep brain stimulators, to avoid electrophysiological interference.
  • Non-pregnant and non-lactating women, in accordance with regulatory requirements for minimal-risk research.

You may not qualify if:

  • Open facial wounds, active infections, significant skin lesions, or a history of severe allergy.
  • Severe cognitive impairment, psychiatric disorders, or inability to comply with study procedures.
  • Occurrence of serious adverse events or withdrawal at the patient's request.
  • Pregnant or lactating women, or patients unable to use appropriate contraceptive measures during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Peoples's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University

Changzhou, Jiangsu, 213000, China

Location

Related Publications (7)

  • Soekadar SR, Witkowski M, Birbaumer N, Cohen LG. Enhancing Hebbian Learning to Control Brain Oscillatory Activity. Cereb Cortex. 2015 Sep;25(9):2409-15. doi: 10.1093/cercor/bhu043. Epub 2014 Mar 13.

  • Jitsinthunun T, Li C, Ng TK, Zinboonyahgoon N. Pulsed Radiofrequency Treatment: Evidence for and Applications in Chronic Pain. Pain Physician. 2025 Nov;28(6):467-481.

  • Sam J, Catapano M, Sahni S, Ma F, Abd-Elsayed A, Visnjevac O. Pulsed Radiofrequency in Interventional Pain Management: Cellular and Molecular Mechanisms of Action - An Update and Review. Pain Physician. 2021 Dec;24(8):525-532.

  • Liu Z, Xie D, Wen X, Wang R, Yang Q, Liu H, Shao Y, Liu T. Peripheral Repetitive Transcranial Magnetic Stimulation(rTMS) for Idiopathic Facial Nerve Palsy: A Prospective, Randomized Controlled Trial. Neural Plast. 2022 Jul 13;2022:7536783. doi: 10.1155/2022/7536783. eCollection 2022.

  • Li D, Li R, Song Y, Qin W, Sun G, Liu Y, Bao Y, Liu L, Jin L. Effects of brain-computer interface based training on post-stroke upper-limb rehabilitation: a meta-analysis. J Neuroeng Rehabil. 2025 Mar 3;22(1):44. doi: 10.1186/s12984-025-01588-x.

  • Cervera MA, Soekadar SR, Ushiba J, Millan JDR, Liu M, Birbaumer N, Garipelli G. Brain-computer interfaces for post-stroke motor rehabilitation: a meta-analysis. Ann Clin Transl Neurol. 2018 Mar 25;5(5):651-663. doi: 10.1002/acn3.544. eCollection 2018 May.

  • Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, Filipovic SR, Grefkes C, Hasan A, Hummel FC, Jaaskelainen SK, Langguth B, Leocani L, Londero A, Nardone R, Nguyen JP, Nyffeler T, Oliveira-Maia AJ, Oliviero A, Padberg F, Palm U, Paulus W, Poulet E, Quartarone A, Rachid F, Rektorova I, Rossi S, Sahlsten H, Schecklmann M, Szekely D, Ziemann U. Corrigendum to "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)" [Clin. Neurophysiol. 131 (2020) 474-528]. Clin Neurophysiol. 2020 May;131(5):1168-1169. doi: 10.1016/j.clinph.2020.02.003. Epub 2020 Feb 19. No abstract available.

MeSH Terms

Interventions

Brain-Computer InterfacesTranscranial Direct Current StimulationStandard of Care

Intervention Hierarchy (Ancestors)

Electrical Equipment and SuppliesEquipment and SuppliesElectric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
phD

Study Record Dates

First Submitted

December 25, 2025

First Posted

January 8, 2026

Study Start

November 30, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

January 8, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

IPD will not be shared because the study involves sensitive clinical and neurophysiological data, and full de-identification cannot be guaranteed without compromising participant privacy. In addition, the informed consent obtained from participants did not include provisions for public data sharing.

Locations